Clinical Trials in San Diego

Showing 5981-6000 of 14,679 trials

Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain

NCT02460692

This study will involve treating low back pain associated with nerve injury with oral delta-9-tetrahydrocannabinol (Δ9-THC) or whole plant cannabis for eight weeks. Research subjects will consume either oral Δ9-THC (dronabinol), vaporized 3.7% Δ9-THC/5.6% CBD, or placebo. An analysis will then be determined to assess the risk--benefit ratio of dronabinol and vaporized 3.7% Δ9-THC/5.6% CBD .

CannabisLow Back PainNeuropathic Pain

University of California, San Diego131 participantsStarted Dec 2016

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

NCT01940341

The primary objective of this study is to compare the efficacy, safety, and tolerability of tenofovir alafenamide (TAF) versus tenofovir disoproxil fumarate (TDF) in treatment-naive and treatment-experienced adults with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection.

HBeAg-negative Chronic Hepatitis B

Gilead Sciences426 participantsStarted Sep 2013

Los Angeles, California, United States • Palo Alto, California, United States • Pasadena, California, United States +102 more locations

Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Find Trials by Condition in San Diego

Study of Leukocyte Interleukin, Injection for Treatment of Perianal Warts

Immune Modulators for Treating COVID-19

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Study of Exchange of Travoprost Intraocular Implant

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

A Study of Duvelisib in Combination With Rituximab or Obinutuzumab in Subjects With Previously Untreated CD20+ Follicular Lymphoma (CONTEMPO)

Impact of Fever Prevention in Brain Injured Patients

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer